| Literature DB >> 35392809 |
Helene Sedelius1,2, Malin Tistad3,4, Ulrika Bergsten5, Mats Dehlin6, David Iggman7, Lars Wallin3, Anna Svärd7.
Abstract
BACKGROUND: Gout affects nearly 2 % of the population and is associated with repeated painful flares of arthritis. Preventive urate-lowering therapy is widely available, but only one third of patients receive adequate treatment. Lack of knowledge among healthcare professionals and patients within primary healthcare are implicated as partial explanations for this undertreatment. Nurse-led care has proved to be an effective model when treating patients with gout, but there is a need for more knowledge about factors that can be expected to influence the future implementation of such care. The aim of this study was to describe factors influencing existing gout care in primary healthcare and the conditions for a future implementation of nurse-led gout care based on national treatment recommendations.Entities:
Keywords: Experiences; Gout; I-PARIHS; Implementation; Nurse-led care; Personnel experiences; Primary healthcare
Mesh:
Substances:
Year: 2022 PMID: 35392809 PMCID: PMC8988383 DOI: 10.1186/s12875-022-01677-z
Source DB: PubMed Journal: BMC Prim Care ISSN: 2731-4553
Swedish treatment recommendations [12]
One gout flare in combination with at least one of the following risk factors for recurrent disease requires long-term pharmacological urate lowering treatment (ULT), sometimes life-long: | |
| • age below 40 years | |
| • urate level > 480 μmol/L | |
| • more than one flare | |
| • multiple joint engagement | |
| • skeletal effects | |
| • comorbidities | |
| • tophi or urate stone | |
| ULT should be increased stepwise in dose to achieve target levels of urate; 360 μmol/L in uncomplicated gout and < 300 μmol/L if tophi are present (normal urate levels without gout are in the range 155–480 μmol/L). | |
| • lifestyle changes, including reduced alcohol consumption | |
| • appropriate diet | |
| • weight loss | |
| • physical activity | |
| • individualised patient education |
Participants per PHC unit
| PHC unit /focus group | Nurses (n) | Physicians (n) | Managers (n) |
|---|---|---|---|
| 5 | 1 | 1 | |
| 3 | 3 | 1 | |
| 4 | 4 | 1 | |
| 2 | 3 | 1 | |
| 3 | 3 | 1 | |
| 3 | 3 | 1 | |
| 2 | 4 | 1 | |
| 2 | 4 | 0 | |
| 3 | 4 | 1 |
aOne focus group from each PHC unit
Information about participants
| Nurses | Physicians | Managers | Total | |
|---|---|---|---|---|
Age (years) | 49 (27–65) | 47 (30–66) | 54 (39–64) | 49 (27–66) |
Females | 24 (89) | 11 (38) | 8 (100) | 43 (67) |
Work experiencea (years) | 8 (1–39) | 12 (1–34) | 17 (5–29) | 11 (1–39) |
aIn primary healthcare
The i-PARIHS’ main constructs, definitions [18]
| Innovation | Recipients | Context (and) |
|---|---|---|
| What is to be implemented | Perspectives and characteristics of the individuals and teams to be affected by the innovation | Setting for the implementation Local and organisational |
An overview of constructs and categories
| Constructs | Categories |
|---|---|
| Primarily patient-initiated contacts | |
| Complexity of diagnostics and preventive treatment | |
| Nurse-led care; a favourable organisational model when time allows | |
| A low-priority condition with acute flares | |
| Variations in knowledge about gout and belief in preventive treatment | |
| A holistic but fragmented responsibility with limited resources | |
| Adopting new evidence requires supportive strategies and motivation | |
| Aggravating circumstances related to systems and recommendations |
An example of a category and its sub-categories
| Category | Sub-categories |
|---|---|
| Complexity of diagnostics and treatment | Clinical practice dependent on physician involved |
| A diagnostic dilemma | |
| Prevention too time-consuming | |
| Self-care commona | |
| Emphasising the importance of treatment depending on patient preferencesb |
aOnly expressed by nurses and physicians
bOnly expressed by managers